London, UK, December 10, 2024 – Relation, an industry leader in deploying computation and experimentation to drug discovery, today announced two multi-program strategic collaborations with GSK. The ...
The Swiss pharma group Novartis has entered a multi-program strategic collaboration with London-based biotech Relation Therapeutics to discover and develop novel treatments for atopic diseases such as ...
Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback